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Male flies hypertranscribe most genes along their single X chromosome to match the output of females with two X chromosomes. This is
mediated by chromatin modifications carried out by the MSL complex composed of noncoding roX RNA and at least five MSL proteins.
New results indicate that one of these subunits, the MOF acetyltransferase, not only acts on histone H4, but on itself and MSL3. Cycles of
covalent modifications of the MSL subunits may determine the proper level of hypertranscription or control cis spreading along the
chromosome. The MSL complex binds to the roX genes, the very source of the RNA component of the complex. New details of how this
interaction occurs hint at a possible autoregulatory function. Finally, despite intensive efforts, the molecular mechanism by which the MSL
complex distinguishes the X from the autosomes remains a mystery. The MSL complex is able to spread epigenetically from the site of roX
transcription, and recent work has defined the conditions that control local cis spreading. However, it is equally clear that soluble MSL
complex can distinguish the X chromosome from autosomes. Reconciling all these findings into a unified model presents a challenge.
D 2004 Elsevier Inc. All rights reserved.Keywords: Dosage compensation; Chromatin; roX RNA; MSL; Histone acetylation; DrosophilaIntroduction
Epigenetic mechanisms of gene regulation have generat-
ed great interest over the last decade as the central role that
chromatin architecture plays in gene expression has become
clear (Jenuwein and Allis, 2001). A striking example of
global control mediated by chromatin packaging is dosage
compensation of the X chromosome. In many organisms,
females have two X chromosomes while males have only
one. Chromatin-based solutions have evolved to equalize
gene expression between the sexes. Several recent reviews
provide a comprehensive analysis of the entire field (Cline
and Meyer, 1996; Meller and Kuroda, 2002; Meyer, 2000;
Park and Kuroda, 2001; Plath et al., 2002). Here I will
concentrate only on new developments in understanding
dosage compensation in Drosophila.
Dosage compensation in flies is mediated by a huge
RNA–protein complex (the MSL complex, MWt approxi-
mately 2  106) that binds to hundreds of sites along the
male X chromosome. Most of the genes along the single0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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E-mail address: rkelley@bcm.tmc.edu.male X chromosome are presumed to be hypertranscribed
about twofold by the MSL dosage compensation complex to
match the transcriptional output of the female’s two X
chromosomes (Henry et al., 2001; Kelley and Kuroda,
2003). The striking feature of this system is that there are
several thousand unrelated genes distributed along the X.
Each is expressed at different levels, tissues, and times of
development in response to different sets of transcription
factors. Yet, the MSL complex must act on nearly all of
them. How dosage compensation is targeted to the genes
located on the X and not those on autosomes has been a
major question in the field.
Dosage compensation in flies provides a spectacular
example of noncoding RNAs targeting chromatin modifica-
tion to a specific region of the genome. The roX (RNA on the
X chromosome) RNAs are components of the MSL complex
and ‘‘paint’’ the male X in a highly reproducible, banded
pattern (Meller et al., 2000). The male autosomes are mostly
free of MSL complex, but a few autosomal sites do consis-
tently attract complex, and this number can be increased by
overexpressing the MSL proteins (Demakova et al., 2003). It
is not known what the MSL complex might be doing at these
few autosomal sites. At the resolution of the light (Bone et
al., 1994) or electron microscope (Semeshin et al., 2002), the
MSL complex is associated only with actively transcribed X-
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somes. The largely inactive polytene bands are mostly MSL
negative. Polytene chromosomes found in certain postmi-
totic cells are composed of approximately 1000 sister chro-
matids aligned in register and are the preferred material for
cytological analysis because of their size. At a gross level,
the MSL and roX distribution patterns seen in polytene cells
reflect what also occurs in much smaller diploid cells
(Buscaino et al., 2003; Gu et al., 2000).
Each of the five MSL proteins displays a distinctive
male-specific lethal phenotype when removed by mutation.
A sixth protein, JIL1, appears to interact with the MSL
complex, but has additional essential functions in both sexes
(Wang et al., 2001). MOF, one of the MSL subunits, and
JIL1 are each chromatin-modifying enzymes that are
thought to directly mediate hypertranscription. MOF is a
histone H4 acetyltransferase (Akhtar and Becker, 2000;
Smith et al., 2000), and JIL1 is a histone H3 kinase (Wang
et al., 2001). The other subunits are MSL1, novel (Palmer et
al., 1993); MSL2, a RING finger protein (Bashaw and
Baker, 1995; Kelley et al., 1995; Zhou et al., 1995);
MSL3, a chromodomain protein (Koonin et al., 1995; Marin
and Baker, 2000); and MLE, a helicase (Kuroda et al., 1991;
Lee et al., 1997). Homologs of each MSL protein are found
in mammals (Marin, 2003; Marin and Baker, 2000; Marin et
al., 2000; Sanjuan and Marin, 2001).Functions of roX RNAs
Along with the mammalian Xist RNA, roX RNAs are so
far the only examples of a new class of noncoding RNAs
that paint entire chromosomes. In both animals, the Xist or
roX genes map to the X. Location on the X is absolutely
essential to Xist function (Plath et al., 2002), but the
location of roX genes appears less stringent (see below).Fig. 1. roX gene structure. Both roX1 (above) and roX2 (below) map to the X chrom
deletions are the most commonly used mutant alleles (Meller and Rattner, 2002). T
are complemented by a rescuing cosmid inserted elsewhere. The roX1 transcri
Immediately below is shown a 3.35 kb roX1 cDNA, which has full biological fu
labeled D10 and D11 indicate deletions that strongly reduce activity in vivo while
al., 2003). The hairpin structure at the 3V end of roX1 shows the location of a large R
family of transcripts approximately 600 nt long (Park et al., 2003). The yellow ball
roX1 and roX2 of unknown function (Franke and Baker, 1999). The green boxes i
that form male-specific DNase I hypersensitive sites (DHS) in vivo (Kageyama eThe two known roX RNAs differ greatly in size (3.7 kb vs.
0.6 kb) and share almost no primary sequence homology
(Fig. 1) (Amrein and Axel, 1997). An early study demon-
strated that deleting both roX1 and roX2 prevented the
MSL complex from binding the X chromosome normally
in dying embryos (Franke and Baker, 1999). Subsequent
recovery of a viable roX2 deletion opened the door for
detailed genetic examination (Meller and Rattner, 2002).
Double mutant roX1 roX2 females survived to adulthood,
but their brothers died as larvae because they could not
correctly target the MSL proteins to the X (Fig. 2E). Both
MSL painting of the X and male viability were restored
when either roX1 or roX2 RNA was provided from an
autosomal transgene. This demonstrated that although roX1
and roX2 RNAs do not resemble one another, they are
functionally interchangeable. This analysis also showed
that although roX1 and roX2 are mutually redundant, there
is not a third genetically redundant roX-like gene that had
escaped detection. This conclusion is consistent with the
inability to recover additional roX species in dedicated
screens (Fujii and Amrein, 2002; Oh et al., 2003).
A deletion study of roX1 came to the startling conclusion
that the bulk of the approximately 3.7 kb roX1 sequence is
not needed for function. A 3.35 kb roX1 cDNA lacking the
5V approximately 350 nt appears to have full activity (Meller
and Rattner, 2002; Stuckenholz et al., 2003). Almost any
10% of this cDNA sequence could be removed in 300 nt
intervals without strongly affecting activity in vivo (Stuck-
enholz et al., 2003). This begins to explain how the much
smaller roX2 can be functionally interchangeable. Deletions
near the 3V end did cripple the truncated roX1 RNA indicat-
ing that critical elements are found at that end (Fig. 1). A
functionally important, long dsRNA stem-loop is located
within the critical 3V region of roX1 (Stuckenholz et al.,
2003). This study remarkably parallels a similar mutational
analysis of mammalian Xist RNA that found most smallosome at positions 3F and 10C, respectively. The roX1ex6 and Df(1)roX252
he roX2 deletion is much larger than shown, but the other missing sequences
pt has a small intron, which is frequently retained in mature transcripts.
nction despite missing several hundred nt from the 5Vend. The blue boxes
comparable sized deletions elsewhere had little or no effect (Stuckenholz et
NA stem-loop structure required for full activity. The roX2 gene produces a
s indicate the most conspicuous blocks of sequence identity shared between
ndicate approximately 220 bp binding sites for the MSL complex (red ball)
t al., 2001; Park et al., 2003).
Fig. 2. MSL complex binding. The X chromosome of wild-type males is painted in a banded pattern of MSL complex (red) (A). Centric heterochromatin is
symbolized as a thin line at the right end (not to scale). Only chromatin entry sites bind partial MSL complexes in msl3, mof, or to a lesser degree, in mle
mutants (B). Two of the entry sites are the endogenous roX1 (left) and roX2 (center) genes. The roX genes can attract even partial complexes to autosomal
transgenes (Kelley et al., 1999). In both roX1 (C) or roX2 (D) single deletion mutants, the MSL complex paints the X normally and males are viable. Males
lacking both roX1 and roX2 are unable to correctly target the MSL complex to the X and die (E) (Meller and Rattner, 2002). Without roX RNAs, the MSL
proteins paint the X only faintly, ectopically bind some autosomal sites and centric heterochromatin (red ball in E). Local spreading of the MSL complex from
autosomal roX transgenes occurs almost never if the X is wild type (F), in about 5–20% of nuclei if only one roX gene is functional on the X (G), but in 100%
of nuclei if the transgene is the only source of roX RNA (H) (Park et al., 2002). The presence of a second roX transgene on an autosome suppresses local MSL
spreading as effectively as the endogenous roX genes on the X (I). A roX1 cDNA clone transcribed from the Hsp83 promoter (yellow box) will not support
local MSL spreading (J) (Meller and Rattner, 2002; Park et al., 2002; Stuckenholz et al., 2003), but local spreading is observed when the same cDNA is
transcribed from an uncharacterized promoter in flanking DNA (K) (Kageyama et al., 2001). Overexpressing both MSL1 and MSL2 proteins distorts the
morphology of the X, especially if only one roX gene is functional (Oh et al., 2003). If roX1 is deleted, most of the MSL complex is concentrated around the
middle of the X where roX2+ is located with little reaching more remote parts of the X (L). The race to assemble model postulates that under conditions of low
roX transcription and abundant MSL proteins (colored ovals), complex assembly is completed before RNA polymerase reaches the 3V end of the gene (Oh et al.,
2003). Active complex is postulated to immediately bind chromatin and spread in cis regardless of DNA sequence (M). Under conditions of high roX
transcription and lower MSL subunit availability, assembly is less efficient. Nascent transcripts are released by 3V processing before maturation and finish
assembly in solution (N). Soluble complex subsequently binds the X using an unknown mechanism.
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Similarly, much of telomerase RNA can be deleted and yet
retain function (Autexier and Greider, 1998; Roy et al.,
1998).The MSL proteins appear to have weak affinity for the X
chromosome that is greatly enhanced by roX RNA. Over-
expression of the MSL proteins significantly increases the
number of escaper roX1 roX2 males recovered as adults
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directly responsible for chromatin modifications and the roX
RNAs help direct their action. Earlier work using mle
mutants had arrived at a similar conclusion. Without MLE
helicase, roX RNAs are not incorporated into MSL com-
plexes, but incomplete complexes containing MSL1, MSL2,
MSL3, and MOF remain bound to a few dozen sites along
the X (Gu et al., 2000; Meller et al., 2000).
If roX RNA is responsible for high affinity binding of the
MSL complex to the entire X, how might this occur? The
RNA might provide a scaffold upon which the MSL
proteins are arranged in the correct spatial orientation. The
MLE, MOF, and MSL3 subunits have all been shown to
bind RNA (presumably roX RNA) in vivo (Akhtar et al.,
2000; Buscaino et al., 2003; Richter et al., 1996). The MLE
helicase might provide an RNAwinding/unwinding activity
that mediates large-scale conformational changes in the
complex during cycles of activity or translocating along a
chromosome. A more exotic possibility is that roX RNA
contributes to sequence specificity by invading chromosom-
al DNA on the X to form short heteroduplexes. At least in
vitro, MLE can act on RNA/DNA heteroduplexes (Lee et
al., 1997). A similar RNA-mediated DNA recognition
mechanism operates in some epigenetic gene silencing
pathways in plants (Aufsatz et al., 2002) and fission yeast
(Verdel et al., 2004).The MSL complex binds to roX genes
It is useful to consider multiple modes of binding
between the MSL proteins or complete complex and various
classes of targets along the X. Complete MSL complexes
are required to bind most targets thought to be ordinary
genes requiring dosage compensation (Fig. 2A). Removal of
MOF or MSL3 through mutation causes the complex to be
lost from most sites on the X, but partial complexes are
retained at about 30 sites scattered fairly evenly along the X
(Fig. 2B) (Gu et al., 2000; Kelley et al., 1999; Lyman et al.,
1997). The molecular identity of these sites is of great
interest because the only two that have been isolated turned
out to be the roX genes themselves. Binding to the roX
genes differs subtly from the other 30 sites in being
especially dependent on MLE helicase and roX RNA
(Kageyama et al., 2001; Meller et al., 2000; Park et al.,
2003).
A common point of confusion arises from the fact that
MSL proteins bind to both roX RNAs and roX genes. This is
analogous to the well-characterized Zn finger protein
TFIIIA binding the internal control sequence within 5S
rRNA genes to drive transcription as well as the 5S rRNA
product to form 7S storage particles (Sands and Bogenha-
gen, 1987). When MSL proteins are seen at a roX gene, it is
not immediately clear whether the proteins are bound to the
gene’s DNA or nascent RNA transcripts enveloping the
gene. With that caution in mind, complete and some partialMSL complexes bind the roX genes in vivo, even if they are
moved onto autosomes (Kelley et al., 1999). An approxi-
mately 220 bp region within both roX1 and roX2 is
necessary and sufficient to attract the MSL complex, and
both form male-specific DNase I hypersensitive sites (DHS)
in vivo (Fig. 1) (Kageyama et al., 2001; Park et al., 2003).
Binding occurs in the absence of roX transcription indicat-
ing that DNA (or chromatin) is recognized. RNAs lacking
the DHS region function normally, supporting the notion
that the sequence acts as a DNA recognition element, rather
than as RNA (Park et al., 2003; Stuckenholz et al., 2003).
The MSL proteins require roX RNA to recognize the DHS
element (Park et al., 2003). The DHS regions of roX1 and
roX2 share short islands of primary sequence that have been
conserved over evolution, and mutations in the conserved
elements reduce MSL binding (Park et al., 2003). This is the
first report of the MSL complex recognizing (directly or
indirectly) a specific DNA sequence. Initial computer
searches of the Drosophila genome failed to detect addi-
tional DHS-like sequences, so it is not known if this finding
will help explain the more general problem of how the MSL
complex distinguishes genes on the X from those on the
autosomes.
One of the more conspicuous features of the DHS is the
presence of multiple GAGA sequences (Park et al., 2003).
In mutants lacking roX RNA, a large fraction of the MSL
proteins leaves the X and relocates to centric heterochro-
matin (Meller and Rattner, 2002; Oh et al., 2003; Park et al.,
2003). The reason for this is not known, but one of the more
abundant satellite sequences (IV) found in centric hetero-
chromatin has the sequence (AAGAGAG)n. No biochemical
evidence is available to determine if any of the individual
MSL proteins or roX RNAs makes direct contacts with the
DHS, or if an uncharacterized intermediate is required. It is
notable that GAGA-binding factor encoded by the trl gene
often mobilizes nucleosomes to create DNase I hypersensi-
tive sites in other contexts (Leibovitch et al., 2002; Pile and
Cartwright, 2000; Wall et al., 1995).
What is the biological consequence of complete or partial
MSL complex binding to roX genes? The MSL complex
usually equalizes X-linked gene expression between males
and females, but this is clearly not the case with the roX
genes. One idea was that a subset of MSL subunits might
preposition themselves on the roX DNA to capture nascent
transcripts and begin complex assembly. However, this
seems unlikely because deletion of the DHS does not
noticeably affect complex assembly (Park et al., 2003;
Stuckenholz et al., 2003). A second idea was that DHS
elements were the initial binding sites to drive spreading of
the MSL complex into flanking chromatin (see below).
However, to date, no evidence of cis spreading from an
individual DHS has been presented (Park et al., 2003).
Occasional cis spreading of MSL complex was seen from
a roX1 DHS multimer construct, but the significance of this
observation is not understood (Kageyama et al., 2001). A
third idea is that MSL proteins somehow regulate male-
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1997; Meller, 2003; Meller et al., 1997, 2000). It had been
unclear whether this occurred only through RNA stabiliza-
tion, or if the MSL proteins also regulated roX transcription
initiation. Under certain circumstances, the MSL complex
can mediate an ‘‘ON’’ in male—‘‘OFF’’ in female mode of
expression for genes immediately surrounding roX1 trans-
genes (Kelley and Kuroda, 2003). A recent study found that
MSL2 alone is sufficient to drive male-specific expression
of roX1, but this regulation did not act through the DHS
element (Rattner and Meller, in press). Although the details
are only beginning to emerge, it seems likely that production
of roX RNA, MSL proteins, and assembly of functional
complexes will be tightly coupled.Acetylation of MSL3
The MOF subunit of the MSL complex is a well-
characterized histone acetyltransferase acting on Lys16 of
histone H4 (Akhtar and Becker, 2000; Smith et al., 2000).
Recent work has shown that MOF not only autoacetylates
itself, but acetylates a single lysine residue in the MSL3
subunit (Buscaino et al., 2003). The authors show that
MSL3 association with the X is RNA dependent, and
acetylation of MSL3 reduces its affinity for roX2 RNA. If
left unchecked, acetylation causes MSL3 to fall off the X
chromosome. Rapid deacetylation by the RPD3 enzyme
appears to keep MSL3 bound to the MSL complex on the
X. These exciting results suggest that cycles of covalent
modifications of the individual MSL subunits control a
delicate balance between active and inactive complex. This
might fine tune dosage compensation to achieve the desired
twofold effect or mediate movement of the complex along
the chromosome.
The site on MSL3 (K116) that is acetylated is especially
interesting because it immediately follows the chromodo-
main near the N-terminus (Fig. 3). The well-characterized
chromodomain from HP1 binds methylated histone tails
(Jacobs and Khorasanizadeh, 2002; Nielsen et al., 2002),
but the distantly related chromodomains in both MOF and
MSL3 seem to bind RNA instead (Akhtar et al., 2000).
Mutating the critical lysine residue in MSL3 to arginineFig. 3. MOF acetylates histone H4 and MSL3. The sequence of the amino terminus
MOF acetylation. Below is shown the sequence alignment of the second half of M
share the same highlight color. The black block indicates the position of acetylati
occupied by arginine. The insect species are D. melanogaster, D. pseudoobscur
sequences were derived from conceptual translation of genomic DNA.blocked acetylation (Buscaino et al., 2003), and yet in all
known MSL3 orthologs, this position is normally occupied
by arginine (Fig. 3). One explanation might be that D.
melanogaster has recently evolved a novel regulatory sys-
tem absent in D. pseudoobscura and D. virilis (divergence
of approximately 28 and 40 MY, respectively). However,
the authors argue for an ancient regulatory mechanism based
on the presence of MOF-like and MSL3-like proteins in
chromatin remodeling complexes in many species (Bus-
caino et al., 2003). Another explanation is that MSL3
proteins from other species are acetylated at different sites.
This issue should be quickly resolved by examining trans-
genic flies whose only source of MSL3 protein carries the
K116R mutation.Distinguishing the X from autosomes
Perhaps the most perplexing aspect of dosage compen-
sation has been trying to understand how the MSL complex
distinguishes the X from the autosomes. Two general classes
of models have been considered. For years there was a
widely held assumption that soluble MSL complex would
recognize a short enhancer-like sequence near most X-
linked genes that would be absent from the autosomes. No
evidence for such a sequence was found (Qian and Pirrotta,
1995), and to date, none of the MSL proteins have obvious
DNA-binding motifs. However, now that the genome se-
quence is available, clever informatics searches could be
very interesting.
More recently, an epigenetic model has been considered
where the MSL complex initially binds only a few dozen
‘‘chromatin entry sites’’ scattered along the X and subse-
quently spreads in cis to find final target genes, largely
independent of any particular DNA sequence. This model
was proposed to explain sporadic cases of MSL complex
spreading from roX transgenes inserted on autosomes (Kel-
ley et al., 1999), and was inspired by the precedent of Xist
RNA coating the inactive X in female mammals. Such an
epigenetic model readily accommodates the observation that
autosomal genes often become dosage compensated when
moved to the X (Spradling and Rubin, 1983). Likewise,
totally foreign genes inserted onto the Drosophila X becomeof histone H4 is shown on top with lysine 16 in black to indicate the site of
SL3’s chromodomain from different species. Conserved amino acid residues
on, lysine 116, in melanogaster. The comparable codon in other species is
a, D. virilis, and Anopheles gambiae. D. pseudoobscura and A. gambiae
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(Sass et al., 2003) as would be expected if the MSL complex
recognized some feature of active chromatin rather than a
particular DNA sequence.
The initial reports of MSL cis spreading found that it
occurred in a highly variable mosaic pattern in a small
fraction of nuclei, and often only extended a few polytene
bands (few hundred kb) from the site of roX transcription
(Fig. 2G) (Kelley et al., 1999; Meller et al., 2000). For
comparison, the euchromatic portion of the Drosophila X is
about 21 Mbp long. These initial experiments happened to
be carried out in roX1 roX2+ males. A dramatically
different result was obtained when the same roX transgenes
were tested in roX1 roX2 double mutant males in which
the only source of roX RNA came from the autosomal
transgene. Under these unusual conditions, the MSL com-
plex spread >1 Mbp from the roX transgene in essentially all
nuclei (Fig. 2H) (Park et al., 2002). Discovering conditions
that permitted consistent spreading of MSL complex over
large segments of autosome supports the idea that some type
of sequence-independent recognition mechanism is at work.
However, some of these results pose difficult questions.
For instance, cis spreading was strongly inhibited or totally
blocked by the presence of a second roX gene anywhere in the
same nucleus (Figs. 2F–I). This was due to multiple sources
of roX transcripts competing for a limiting pool of free MSL
subunits with which to assemble complexes (Park et al.,
2002). Finding that pairs of roX genes inhibit local spreading
from one another was unexpected because there are normally
two roX genes on the X. Providing additional MSL1 and
MSL2 proteins (the subunits thought to be most limiting)
shifted conditions to favor cis spreading (Park et al., 2002).
Pushed to the extreme, these same conditions could shift the
bulk of MSL distribution almost entirely into local spreading
around either endogenous roX gene on the X (Fig. 2L). These
conditions made it difficult to deliver normal levels of MSL
complex to distal regions of the X far removed from the site of
roX transcription (Oh et al., 2003). These findings show that
roX genes are the strongest, and perhaps only, initiation points
for MSL spreading on the X.
Another puzzling observation was that MSL complex
only spread in cis from normal genomic clones of roX1 or
roX2 transcribed by their native promoters. Transgenes
expressing a roX cDNAs from strong Hsp83 or Hsp70
promoters produced functional MSL complexes that painted
the X, but no local spreading was observed around the roX
transgenes (Fig. 2H vs. J) (Meller and Rattner, 2002; Park et
al., 2002; Stuckenholz et al., 2003). The failure of RNAs
derived from cDNA clones to spread locally might be due to
critical sequences at the 5V end missing from the cDNA
clones or important spreading initiation sites immediately
flanking the wild-type roX genes. This seems not to be the
case. The same roX1 sequence was able to support moder-
ately consistent local spreading if the Hsp83 promoter was
removed, and the cDNA was instead transcribed from a
weaker promoter fortuitously located in flanking chromatin(Fig. 2K) (Kageyama et al., 2001). Perhaps the level of roX
transcription somehow affects the likelihood that MSL
complex spreads locally. These and other results have been
incorporated in a highly speculative ‘‘race to assemble’’
model where local MSL spreading is favored when roX
transcription is low and/or MSL proteins are abundant (Figs.
2M, N) (Oh et al., 2003; Park et al., 2002). This relies on the
assumption that MSL proteins assemble on nascent roX
transcripts as they emerge from RNA polymerase. Earlier
work had suggested that the MSL subunits quickly assemble
onto nascent roX transcripts, possibly cotranscriptionally
(Meller et al., 2000). If this model survives experimental
tests, it is still not clear what biological function would be
served by linking local spreading with the kinetics of MSL
complex assembly.
If the roX genes were the primary markers denoting the X
chromosome as the target for dosage compensation, deleting
them from the X and moving both onto the same autosome
might have been expected to grossly disrupt dosage com-
pensation. First, the mutant X might be mistaken for an
autosome and fail to attract MSL complex. Conversely, the
autosome harboring the roX transgenes might be mistaken
for the X and be inappropriately hypertranscribed over
much of its length. When such males were constructed, all
of the MSL complex correctly reached the X with little or no
MSL spreading from the autosomal roX genes (Fig. 2I)
(Park et al., 2002). This outcome demonstrates that soluble
MSL complex is targeted to the X by some feature other
than the roX genes. This simply extends earlier observations
that showed roX RNAs (within MSL complexes) could
move between chromosomes (Kageyama et al., 2001; Kel-
ley et al., 1999; Meller and Rattner, 2002; Meller et al.,
1997). If the X chromosome is not designated by the
presence of roX genes, what other features could be recog-
nized by soluble MSL complex?
The spreading model never postulated that the MSL
complex spread exclusively from the two roX genes to
cover the entire X because, at best, epigenetic spreading
extended only a megabase or two, never 21 Mbp. Instead,
soluble MSL complex was postulated to recognize approx-
imately 30 chromatin entry sites as additional initiation
points for local spreading (Kelley et al., 1999). Although
the other entry sites have not been characterized at the
molecular level, we now suspect that they do not contain
additional roX-like genes. If MSL spreading truly depends
upon local roX transcription (Oh et al., 2003; Park et al.,
2002), then an entirely distinct mechanism of spreading
must be invoked for the other sites. And yet, if any other
entry site does support cis spreading of the MSL complex, it
must be drastically less potent than roX1 or roX2 genes (Oh
et al., 2003). Thus, while the entry sites cannot be rigorously
excluded as the key markers of the X, their role is in doubt.
We are left with the knowledge that epigenetic spreading
of the MSL complex from sites of roX transcription can
clearly occur under certain conditions. However, those
conditions seem unlikely to prevail in wild-type males.
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regardless of where roX RNA is transcribed, but the features
of the X recognized remain a mystery.
In the coming few years, we can anticipate major
advances in understanding how transcription of the roX
genes is controlled, the biochemical functions of the indi-
vidual MSL subunits, the first models of how roX RNAs
fold and recognize MSL proteins, how the X is distin-
guished from the autosomes, and what the role that local
spreading plays in MSL function. The path may be covered
with roX, but the trip will be well worth the effort.References
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